ALS disrupted: FDA approves Japanese drug that slows decline by 33%
Late Friday, MT Pharma America broke the news that the FDA had approved its experimental amyotrophic lateral sclerosis (ALS) drug Radicava, the second-ever drug approved for ALS and the first in over 20 years.